NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE
$639,151N02FY2022CANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
NEXT DTP-22-013, PRODUCTION OF TAK-243 INJECTABLE FOR CLINICAL USE AND STUDY THE SHELF-LIFE.
View original record on NIH RePORTER →